U.S. Global Investors (USGI)’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-7,300
Closed -$281K 148
2018
Q3
$281K Sell
7,300
-200
-3% -$7.36K 0.14% 119
2018
Q2
$263K Buy
+7,500
New +$262K 0.12% 122

Other funds holding FFTY

U.S. Global Investors (USGI)'s FFTY Position: Q4 2018 in Review

U.S. Global Investors (USGI) sold out of CapForce IBD 50 ETF (FFTY) in Q4 2018, closing a stake of 7,300 shares — an estimated $281K sold.

U.S. Global Investors (USGI) first reported a position in FFTY in Q2 2018 and held it in 2 quarters. The position peaked at $281K in Q3 2018. 83 funds tracked by Wall St. Rank hold FFTY as of Q4 2018.

  • U.S. Global Investors (USGI) reported no remaining CapForce IBD 50 ETF position as of Q4 2018 after selling out during the quarter.
  • U.S. Global Investors (USGI) sold 7,300 CapForce IBD 50 ETF shares in Q4 2018, an estimated $281K.
  • U.S. Global Investors (USGI) first reported a position in CapForce IBD 50 ETF in Q2 2018 and held it in 2 quarters.
  • U.S. Global Investors (USGI)'s CapForce IBD 50 ETF position peaked at $281K in Q3 2018.
  • 83 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2018.

Based on U.S. Global Investors (USGI)'s 13F filing for Q4 2018, filed 12 Feb 2019.